Pediatric COVID-19 – a review

R. Castagnoli, I. Brambilla, M. De Filippo, M. Votto, D. Montagna, L. Montagna, A. Licari, G.L. Marseglia

Article ID: 4985
Vol 36, Issue 1S1, 2022
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.202236.1S1.26
Received: 11 March 2022; Accepted: 11 March 2022; Available online: 11 March 2022; Issue release: 11 March 2022

Abstract

In December 2019, in Wuhan (Hubei, China), the first coronavirus disease 2019 (COVID-19) cases due to severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) have been reported. On March 11th, 2020, the World Health Organization (WHO) declared the pandemic. On July 1st, 2021, more than 180 million people had developed the disease, with more than 3.9 million deaths. In Italy, the most updated data show that, among all cases (n= 4.218.979) and deaths (n=125.058) due to COVID-19, 5.5% (n= 231.338) with 11 deaths concern the 0-9 years age group, while 9.6% (n= 406.460) with 15 deaths concern the 10-19 years age group. This review aims to present a comprehensive overview of COVID-19 in children.


Keywords

children;SARS-CoV-2;COVID-19


References

Supporting Agencies



Copyright (c) 2022 R. Castagnoli, I. Brambilla, M. De Filippo, M. Votto, D. Montagna, L. Montagna, A. Licari, G.L. Marseglia




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).